Arcellx Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

6 days ago · ACLX | Complete Arcellx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

86%
OFF

Arcellx, Inc. (ACLX) Stock Price, Quote & News - Stock Analysis

2 weeks from now

5 days ago · Analyst Forecast. According to 14 analysts, the average rating for ACLX stock is "Strong Buy." The 12-month stock price forecast is $107.67, which is an increase of 55.86% …

stockanalysis.com

$83.00
OFF

Arcellx Reaches Analyst Target Price - Nasdaq

2 weeks from now

Oct 14, 2024 · In recent trading, shares of Arcellx Inc (Symbol: ACLX) have crossed above the average analyst 12-month target price of $83.00, changing hands for $86.20/share. When a …

nasdaq.com

7%
OFF

Arcellx (ACLX) Stock Jumps 6.7%: Will It Continue To Soar? - Nasdaq

2 weeks from now

Nov 7, 2024 · Arcellx, Inc. (ACLX) shares rallied 6.7% in the last trading session to close at $92.98. This move can be attributable to notable volume with a higher number of shares being …

nasdaq.com

$261820.57
OFF

Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 In Stock

2 weeks from now

5 days ago · Arcellx, Inc. (NASDAQ:ACLX - Get Free Report) insider Christopher Heery sold 3,553 shares of the company's stock in a transaction that occurred on Wednesday, January …

insidertrades.com

$121.00
OFF

Promising Potential Of Arcellx Inc.: Buy Rating Backed By Strong ...

2 weeks from now

2 days ago · Analyst John Newman from Canaccord Genuity maintained a Buy rating on Arcellx Inc (ACLX – Research Report) and keeping the price target at $121.00. Discover …

businessinsider.com

49%
OFF

(ACLX) - Analyzing Arcellx's Short Interest - Arcellx (NASDAQ:ACLX)

2 weeks from now

1 day ago · Arcellx's ACLX short percent of float has risen 6.49% since its last report. The company recently reported that it has 5.81 million shares sold short , which is 12.3% of all …

benzinga.com

$95
OFF

Arcellx Price Target Raised To $95 From $80 At H.C. Wainwright

2 weeks from now

Nov 5, 2024 · H.C. Wainwright raised the firm’s price target on Arcellx (ACLX) to $95 from $80 and keeps a Buy rating on the shares. The firm says preliminary results from iMMagine-1 are …

nasdaq.com

$115
OFF

Arcellx Price Target Raised To $115 From $73 At Barclays - Nasdaq

2 weeks from now

Nov 30, 2024 · Try Now>>See Insiders’ Hot Stocks on TipRanks >> Read More on ACLX:Arcellx, Inc. Reports Q3 2024 Earnings HighlightsArcellx price target raised to $136 from $87 at …

nasdaq.com

FAQs about Arcellx Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch Coupon?

Who owns arcellx Inc?

The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD. ACLX | Complete Arcellx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ...

Is arcellx (arcellx) a good stock to buy?

Arcellx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings. According to analysts' consensus price target of $43.36, Arcellx has a forecasted upside of 40.7% from its current price of $30.81. ...

Should investors buy arcellx (aclx) stock?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Arcellx in the last twelve months. There are currently 9 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACLX shares. View ACLX analyst ratings or view top-rated stocks. ...

What does arcellx Inc (aclx) do?

The Company provides cancer patients with adaptive immune cell therapies that are readily silenced, activated, and reprogrammed throughout the course of disease. Arcellx serves customers worldwide. Stock analysis for Arcellx Inc (ACLX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ...

How many research reports have been made about arcellx?

Arcellx has only been the subject of 4 research reports in the past 90 days. Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. ...

Where is arcellx based?

The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead. Are You Looking for a Top Momentum Pick? ...